The lack of correlation between CAD severity and chemerin plasma levels in our study may be related to the more accurate effectiveness of CCTA in illustrating the comprehensive burden of atherosclerosis and the existence of atherosclerotic plaques at different stages of the disease relative to the ICA employed for CAD classification in previous investigations [25,26]. This evidence concerns the gene RARRES2 and atherosclerosis.